Kee Pharma Limited, a active public limited company, was established on 08 May 1991 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL1991PLC044264. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.48 Cr.
Formerly known as Kee Pharma P Limited. It upholds a compliant status. Employing 222 professional, Its leadership includes Anil Motihar (Cfo), Harinder Motihar (Director), Varun Motihar (Director). Past directors included Anil Motihar, Harinder Motihar, Taresh Verma. It holds ₹9.50 Cr open charges and ₹4.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 8, 3Rd Floor, Naraina Industrial Area, Phase - Ii,, New Delhi, Delhi, 110028.
U24239DL1991PLC044264
044264
08 May 1991
₹11.00 Cr
₹10.48 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kee Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Motihar | Cfo | 03 Apr 2019 | Current |
| Harinder Motihar | Director | 31 Dec 2015 | Current |
| Varun Motihar | Director | 11 Dec 2014 | Current |
| Natasha Goyal | Additional Director | 22 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Company Secretary | 04 Sep 2007 | Past |
| Pramod Abcsdd | Director | 05 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 31 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kee Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Kee Pharma had a promoter holding of 84.65% and a public holding of 15.35%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹94,980,000.00
₹45,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2004 | Indian Bank | ₹2.95 Cr | Open |
| 11 Sep 2003 | Ge Capital Services India | ₹0.45 M | Open |
| 18 Oct 2002 | Nidian Bank | ₹7.50 M | Open |
| 20 Oct 2000 | Nidian Bank | ₹1.00 Cr | Open |
| 26 Dec 1999 | Indian Bank | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Kee Pharma has a workforce of 222 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kee Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kee Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Natasha Goyal was appointed as a Additional Director was appointed as a Additional Director on 22 Jul 2025 & has been associated with this company since 4 months 10 days . was documented.
Progress on Kee Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Kee Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Anil Motihar was appointed as a CFO was appointed as a CFO on 03 Apr 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The activity Anil Motihar was appointed as a CFO was appointed as a CFO on 03 Apr 2019 & has been associated with this company since 6 years 7 months . was completed.
The activity Harinder Motihar was appointed as a Director was appointed as a Director on 31 Dec 2015 & has been associated with this company since 9 years 11 months . was completed.
The CIN of Kee Pharma Limited is U24239DL1991PLC044264.
Kee Pharma Limited is headquartered at A - 8, 3Rd Floor, Naraina Industrial Area, Phase - Ii,, New Delhi, Delhi, 110028.
Kee Pharma Limited was incorporated on 08 May 1991.
The current directors of Kee Pharma Limited are
The primary industry of Kee Pharma Limited is Manufacturing.
Kee Pharma Limited is unlisted.
The authorized capital of Kee Pharma Limited is ₹11.00 Cr, and the paid-up capital is ₹10.48 Cr.
The compliance status of Kee Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX